[The effect of phepracet and its alkylated derivatives on neuronal populations of the midbrain reticular formation].
D000081:Acetamides / Q000494:pharmacology*; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000662:Amphetamines; D000814:Aniline Compounds / Q000494:pharmacology*; D000818:Animals; D004569:Electroencephalography; D006624:Hippocampus / Q000187:drug effects; D008636:Mesencephalon / Q000187:drug effects*; D008845:Microinjections; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D011941:Receptors, Adrenergic; D012154:Reticular Formation / Q000187:drug effects*; D013329:Structure-Activity Relationship
D000081:Acetamides; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000662:Amphetamines; D000814:Aniline Compounds; D011941:Receptors, Adrenergic; C009756:fepracet; D011433:Propranolol; D010646:Phentolamine
Vliianie fepratseta i ego alkilirovannykh proizvodnykh na neironnye populiatsii retikuliarnoĭ formatsii srednego mozga